Johns Hopkins HIV Guide
Lamotrigine
INDICATIONS
FDA
FDA
- Adjunctive therapy or conversion to monotherapy for partial seizure.
- Generalized seizure of Lennox-Gastaut syndrome.
- Bipolar disorder
NON-FDA APPROVED USES
NON-FDA APPROVED USES
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: October 25, 2016
Citation
Smith, Janessa M, and Paul A Pham. "Lamotrigine." Johns Hopkins HIV Guide, 2016. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545117/all/Lamotrigine.
Smith JM, Pham PA. Lamotrigine. Johns Hopkins HIV Guide. 2016. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545117/all/Lamotrigine. Accessed December 1, 2023.
Smith, J. M., & Pham, P. A. (2016). Lamotrigine. In Johns Hopkins HIV Guide https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545117/all/Lamotrigine
Smith JM, Pham PA. Lamotrigine [Internet]. In: Johns Hopkins HIV Guide. ; 2016. [cited 2023 December 01]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545117/all/Lamotrigine.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Lamotrigine
ID - 545117
A1 - Smith,Janessa,PharmD, BCPS
AU - Pham,Paul,Pharm.D.
Y1 - 2016/10/25/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545117/all/Lamotrigine
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
